Florence Lefresne
Janssen (Belgium)(BE)Janssen (United States)(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Cancer Treatment and Pharmacology, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies
Most-Cited Works
- → Proven bioequivalence of blood exposure between vinorelbine 80 mg/m2 oral and 30 mg/m2 IV doses in cancer patients(2005)179 cited
- → Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry(2020)81 cited
- → Impact of Abiraterone Acetate plus Prednisone or Enzalutamide on Patient-reported Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer: Final 12-mo Analysis from the Observational AQUARiUS Study(2019)61 cited
- → Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multicenter international trial(2021)59 cited
- → Assessment of the Safety of Glucocorticoid Regimens in Combination With Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer(2019)57 cited
- → Oral vinorelbine in combination with cisplatin: a novel active regimen in advanced non-small-cell lung cancer(2003)39 cited
- → Introducing PIONEER: a project to harness big data in prostate cancer research(2020)39 cited
- → Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposures in patients with solid tumours(2007)36 cited
- → Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis(2019)33 cited
- Combination chemotherapy of vinorelbine and cisplatin: a phase I pharmacokinetic study in patients with metastatic solid tumors.(2009)